Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gregory J Dore

Showing results (171-180 of 404) with videos related to

Pageof 41
Sort By:
Hepatology (Baltimore, Md.)|June 9, 2021
Evaluating the Prevention Benefit of HCV Treatment: Modeling the SToP-C Treatment as Prevention Study in PrisonsAaron G Lim, Jack Stone, Behzad Hajarizadeh, et al.
Journal of Gastroenterology and Hepatology|March 10, 2021
Estimating the number of new hepatitis C infections in Australia in 2015, prior to the scale-up of direct-acting antiviral treatmentAnna Y Palmer, Anna Wilkinson, Campbell Aitken, et al.
Hepatology (Baltimore, Md.)|December 31, 2008
Viral dynamics of hepatitis B virus DNA in human immunodeficiency virus-1-hepatitis B virus coinfected individuals: similar effectiveness of lamivudine, tenofovir, or combination therapySharon R Lewin, Ruy M Ribeiro, Anchalee Avihingsanon, et al.
BMC Infectious Diseases|December 2, 2017
Hepatitis C testing and re-testing among people attending sexual health services in Australia, and hepatitis C incidence among people with human immunodeficiency virus: analysis of national sentinel surveillance dataDavid C Boettiger, Matthew G Law, Gregory J Dore, et al.
CMAJ Open|August 1, 2014
Mortality in a large community-based cohort of inner-city residents in Vancouver, CanadaGregory D Deans, Jesse D Raffa, Calvin Lai, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 26, 2013
Assessment and treatment of hepatitis C virus infection among people who inject drugs in the opioid substitution setting: ETHOS studyMaryam Alavi, Jason Grebely, Michelle Micallef, et al.
The Medical Journal of Australia|April 19, 2011
Predictors of deferral of treatment for hepatitis C infection in Australian clinicsHeather F Gidding, Matthew G Law, Janaki Amin, et al.
Journal of Gastroenterology and Hepatology|July 3, 2010
Reinfection with hepatitis C virus following sustained virological response in injection drug usersJason Grebely, Elizabeth Knight, Tyler Ngai, et al.
Journal of Hepatology|April 28, 2023
A 'one-stop-shop' point-of-care hepatitis C RNA testing intervention to enhance treatment uptake in a reception prison: The PIVOT studyYumi Sheehan, Evan B Cunningham, Amanda Cochrane, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 31, 2008
Opportunistic disease and mortality in patients coinfected with hepatitis B or C virus in the strategic management of antiretroviral therapy (SMART) studyEllen Tedaldi, Lars Peters, Jacquie Neuhaus, et al.
Pageof 41

Showing results (171-180 of 404) with videos related to

Sort By:
Pageof 41
Hepatology (Baltimore, Md.)|June 9, 2021
Evaluating the Prevention Benefit of HCV Treatment: Modeling the SToP-C Treatment as Prevention Study in PrisonsAaron G Lim, Jack Stone, Behzad Hajarizadeh, et al.
Journal of Gastroenterology and Hepatology|March 10, 2021
Estimating the number of new hepatitis C infections in Australia in 2015, prior to the scale-up of direct-acting antiviral treatmentAnna Y Palmer, Anna Wilkinson, Campbell Aitken, et al.
Hepatology (Baltimore, Md.)|December 31, 2008
Viral dynamics of hepatitis B virus DNA in human immunodeficiency virus-1-hepatitis B virus coinfected individuals: similar effectiveness of lamivudine, tenofovir, or combination therapySharon R Lewin, Ruy M Ribeiro, Anchalee Avihingsanon, et al.
BMC Infectious Diseases|December 2, 2017
Hepatitis C testing and re-testing among people attending sexual health services in Australia, and hepatitis C incidence among people with human immunodeficiency virus: analysis of national sentinel surveillance dataDavid C Boettiger, Matthew G Law, Gregory J Dore, et al.
CMAJ Open|August 1, 2014
Mortality in a large community-based cohort of inner-city residents in Vancouver, CanadaGregory D Deans, Jesse D Raffa, Calvin Lai, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 26, 2013
Assessment and treatment of hepatitis C virus infection among people who inject drugs in the opioid substitution setting: ETHOS studyMaryam Alavi, Jason Grebely, Michelle Micallef, et al.
The Medical Journal of Australia|April 19, 2011
Predictors of deferral of treatment for hepatitis C infection in Australian clinicsHeather F Gidding, Matthew G Law, Janaki Amin, et al.
Journal of Gastroenterology and Hepatology|July 3, 2010
Reinfection with hepatitis C virus following sustained virological response in injection drug usersJason Grebely, Elizabeth Knight, Tyler Ngai, et al.
Journal of Hepatology|April 28, 2023
A 'one-stop-shop' point-of-care hepatitis C RNA testing intervention to enhance treatment uptake in a reception prison: The PIVOT studyYumi Sheehan, Evan B Cunningham, Amanda Cochrane, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 31, 2008
Opportunistic disease and mortality in patients coinfected with hepatitis B or C virus in the strategic management of antiretroviral therapy (SMART) studyEllen Tedaldi, Lars Peters, Jacquie Neuhaus, et al.
Pageof 41